Table 3. Tyrosine Phosphorylation, Oxidation, and Tyrosine Oxidation with Phosphorylation in Phosphoproteomics Data by Variable Modification Search.
| number
of modified residues |
||||||||
|---|---|---|---|---|---|---|---|---|
| reference | ProteomeXchange data set (PXD) or MassIVE (MSV) IDa | sample type | research topic | raw files | identified peptide sequences | Ox-Y | p-Y | pOx-Y |
| Hoffman et al.25 | PXD001543 | patient samples: skeletal muscle | exercise | 28 | 24 975 | 141 | 151 | 7 |
| Kohtala et al.26 | in vivo: mouse hippocampus | isoflurane anesthesia | 6 | 7400 | 17 | 10 | 7 | |
| Lin et al.27 | PXD017045 | in vivo: mouse kidney | sepsis-induced kidney injury | 18 | 10 240 | 19 | 2 | 4 |
| Rahikainen et al.28 | in vitro: mouse embryonic fibroblast cell line | cell adhesion signaling | 12 | 9780 | 45 | 9 | 7 | |
| Sharma et al.1 | PXD000612 | in vitro: HeLa S3 cervical cancer cell line | phosphoproteomics method development and comparison of S, T, and Y phosphorylation | 141 | 60 471 | 471 | 802 | 51 |
| Tighe et al.29 | MSV000083012a | in vivo: mouse lung | radiation-induced pulmonary fibrosis | 18 | 4204 | 15 | 6 | 4 |
The ProteomeXchange identifier of one data set could not be found.